Godavari Biorefineries Limited (NSE:GODAVARIB)
226.99
-2.28 (-0.99%)
Nov 6, 2026, 3:29 PM IST
Godavari Biorefineries Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 21,311 | 19,879 | 18,703 | 16,867 | 20,147 | 17,023 | |
Revenue Growth | 7.05% | 6.29% | 10.88% | -16.28% | 18.35% | 10.67% |
Cost of Revenue | 15,785 | 14,641 | 14,214 | 12,109 | 14,235 | 12,207 |
Gross Profit | 5,526 | 5,239 | 4,488 | 4,758 | 5,912 | 4,816 |
Selling, General & Admin | 1,436 | 1,377 | 1,278 | 1,183 | 1,166 | 994.31 |
Other Operating Expenses | 2,625 | 2,527 | 2,093 | 2,238 | 3,242 | 2,478 |
Operating Expenses | 4,633 | 4,449 | 3,871 | 4,020 | 4,909 | 3,952 |
Operating Income | 893.21 | 789.79 | 617.09 | 738.38 | 1,003 | 863.75 |
Interest Expense | -472.26 | -455.24 | -636.89 | -704.57 | -666.48 | -539.06 |
Interest & Investment Income | 33.34 | 33.34 | 83.63 | 108.71 | 25.79 | 27.31 |
Currency Exchange Gain (Loss) | -2.32 | -2.32 | -0.26 | - | - | - |
Other Non Operating Income (Expenses) | -50.58 | -33.75 | -80.73 | -17.19 | -35.03 | -26.01 |
EBT Excluding Unusual Items | 401.38 | 331.82 | -17.16 | 125.34 | 327.17 | 325.99 |
Gain (Loss) on Sale of Investments | 0.09 | 0.09 | 0.09 | - | - | - |
Gain (Loss) on Sale of Assets | 25.15 | 25.15 | 1.69 | -0.88 | -9.66 | -5.3 |
Other Unusual Items | -44.82 | -311.38 | -244.94 | - | - | - |
Pretax Income | 381.79 | 45.67 | -260.32 | 124.46 | 317.51 | 320.69 |
Income Tax Expense | 116.02 | 10.39 | -26.18 | 1.48 | 121.14 | 129.72 |
Net Income | 265.77 | 35.28 | -234.14 | 122.98 | 196.37 | 190.97 |
Net Income to Common | 265.77 | 35.28 | -234.14 | 122.98 | 196.37 | 190.97 |
Net Income Growth | 32.36% | - | - | -37.37% | 2.83% | -29.67% |
Shares Outstanding (Basic) | 51 | 51 | 46 | 42 | 42 | 42 |
Shares Outstanding (Diluted) | 51 | 51 | 46 | 42 | 42 | 42 |
Shares Change | 1.42% | 11.58% | 9.35% | - | - | - |
EPS (Basic) | 5.19 | 0.69 | -5.11 | 2.93 | 4.68 | 4.55 |
EPS (Diluted) | 5.19 | 0.69 | -5.11 | 2.93 | 4.68 | 4.55 |
EPS Growth | 30.64% | - | - | -37.39% | 2.86% | -29.68% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -89.69 | 23.96 | -717.73 | 1,299 | -203.7 | -55.3 |
Free Cash Flow Per Share | -1.75 | 0.47 | -15.65 | 30.96 | -4.86 | -1.32 |
Gross Margin | 25.93% | 26.35% | 24.00% | 28.21% | 29.34% | 28.29% |
Operating Margin | 4.19% | 3.97% | 3.30% | 4.38% | 4.98% | 5.07% |
Profit Margin | 1.25% | 0.18% | -1.25% | 0.73% | 0.97% | 1.12% |
Free Cash Flow Margin | -0.42% | 0.12% | -3.84% | 7.70% | -1.01% | -0.33% |
EBITDA | 1,463 | 1,333 | 1,115 | 1,333 | 1,501 | 1,342 |
EBITDA Margin | 6.86% | 6.70% | 5.96% | 7.90% | 7.45% | 7.88% |
D&A For EBITDA | 569.48 | 542.74 | 498.19 | 594.31 | 498.4 | 477.91 |
EBIT | 893.21 | 789.79 | 617.09 | 738.38 | 1,003 | 863.75 |
EBIT Margin | 4.19% | 3.97% | 3.30% | 4.38% | 4.98% | 5.07% |
Effective Tax Rate | 30.39% | 22.75% | - | 1.19% | 38.15% | 40.45% |
Revenue as Reported | 21,416 | 20,002 | 18,869 | 17,011 | 20,231 | 17,100 |